2,3-二氢-5H-噻唑并[3,2-a]吡啶-5-酮 | 66201-75-0

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 2,3-二氢-5H-噻唑并[3,2-a]吡啶-5-酮
• 英文名称: Dihydrothiazolo<3,2-a>pyridin-5-on
• 英文别名: 2,3-dihydro-thiazolo[3,2-a]pyridin-5-one；5H-Thiazolo(3,2-a)pyridin-5-one, 2,3-dihydro-；2,3-dihydro-[1,3]thiazolo[3,2-a]pyridin-5-one
• CAS: 66201-75-0
• 化学式: C₇H₇NOS
• 分子量: 153.205
• InChiKey: LFPSMQVOUAKYAN-UHFFFAOYSA-N

物化性质

• 熔点：
  77 °C(Solv: tetrachloroethylene (127-18-4))
• 沸点：
  431.5±15.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  45.6
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2934100090

反应信息

• 作为产物：
  描述：

  6-amino-2,3-dihydro-thiazolo[3,2-a]pyridinylium 在 硫酸 、 sodium nitrite 作用下， 生成 2,3-二氢-5H-噻唑并[3,2-a]吡啶-5-酮
  参考文献：
  名称：

  Ranger,P.-O. et al., Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry, 1978, vol. 32, p. 70 - 72

  摘要：

  DOI：

文献信息

• [EN] COMPOUNDS AND METHODS FOR TREATMENT OF CHLAMYDIA INFECTIONS<br/>[FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT D'INFECTIONS À CHLAMYDIA
  申请人：QURETECH BIO AB

  公开号：WO2014185853A1

  公开（公告）日：2014-11-20

  The present invention provides new compounds, pharmaceutical compositions and methods for the treatment and diagnosis of Chlamydia infections. The compounds are substituted ring-fused 2-pyridones and are shown to reduce the infectivity of Chlamydia. The invention further identifies the membrane-localized hexose-phosphate permease (UhpC)of Chlamydia as drug target and provides methods for the identification and development of new anti-Chlamydia compounds

  本发明提供了用于治疗和诊断沙眼感染的新化合物、药物组合物和方法。这些化合物是取代环融合的2-吡啶酮，并且已被证明可以减少沙眼的传染性。该发明进一步确定了沙眼的膜定位己糖磷酸透过酶（UhpC）作为药物靶标，并提供了用于识别和开发新的抗沙眼化合物的方法。
• [EN] PYRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF<br/>[FR] DÉRIVÉS DE PYRIDINONE ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES
  申请人：BAYER SCHERING PHARMA AG

  公开号：WO2011076687A1

  公开（公告）日：2011-06-30

  Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-related conditions in both men and women, as well as a mammal in general (also referred to herein as a "subject"). For example, such conditions include endometriosis, uterine fibroids, polycystic ovarian disease, heavy menstrual bleeding, particularly menorrahagia and dysmenorrehea, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reproductive therapy such as in vitro fertilization). The present application relates in particular to pyridinone derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.

  吡啶酮衍生物，其制备方法，其用于治疗和/或预防疾病的用途，以及其用于制造用于治疗和/或预防疾病的药物的用途，特别是用于男性和女性的性激素相关疾病，以及一般哺乳动物（在本文中也称为“受试者”）。例如，这些疾病包括子宫内膜异位症、子宫肌瘤、多囊卵巢综合征、月经过多出血，尤其是月经过多和月经痛、多毛症、早熟、依赖性生殖腺类固醇的肿瘤，如前列腺、乳腺和卵巢癌、性腺激素释放激素依赖性垂体腺瘤、睡眠呼吸暂停、肠易激综合征、经前综合征、良性前列腺增生、避孕和不孕（例如，辅助生殖疗法，如体外受精）。本申请特别涉及吡啶酮衍生物作为促性腺激素释放激素（GnRH）受体拮抗剂。
• [EN] 2,3-DIHYDRO-THIAZOLO[3,2-A]PYRIDIN-5-ONE DERIVATIVES, INTERMEDIATES THEREOF, AND THEIR USE AS ANTIBACERIAL AGENTS<br/>[FR] DÉRIVÉS DE 2,3-DIHYDRO-THIAZOLO [3,2-A] PYRIDIN-5-ONE, LEURS INTERMÉDIAIRES ET LEUR UTILISATION COMME AGENTS ANTIBACTÉRIENS
  申请人：QURETECH BIO AB

  公开号：WO2016075296A1

  公开（公告）日：2016-05-19

  The disclosure relates to certain novel substituted ring-fused thiazolino 2- pyridones of Formula I, to processes for preparing such compounds, to their use in treating a bacterial infection such as a Chlamydia infection, to methods for their therapeutic use and to pharmaceutical compositions containing them.

  该披露涉及某些新型取代环融合噻唑烷基吡啶酮化合物，其化学式为I，涉及制备这类化合物的过程，以及它们在治疗细菌感染，如沙眼衣原体感染中的用途，涉及它们的治疗用途方法以及含有它们的药物组合物。
• 2,3-dihydro-thiazolo[3,2-A]pyridin-5-one derivatives, intermediates thereof, and their use as antibacterial agents
  申请人：Quretech Bio AB

  公开号：US10294244B2

  公开（公告）日：2019-05-21

  The disclosure relates to certain novel substituted ring-fused thiazolino 2-pyridines of Formula I, to processes for preparing such compounds, to their use in treating a bacterial infection such as Chlamydia infection, to methods for their therapeutic use and to pharmaceutical compositions containing them.

  本公开涉及式 I 的某些新型取代环融噻唑 2-吡啶、制备此类化合物的工艺、它们在治疗衣原体感染等细菌感染中的用途、它们的治疗方法以及含有它们的药物组合物。
• Laerum,T.; Undheim,K., Journal of the Chemical Society. Perkin transactions I, 1979, p. 1150 - 1153
  作者：Laerum,T.、Undheim,K.

  DOI：——

  日期：——